Molecular engineering of matrix-targeted retroviral vectors incorporating a surveillance function inherent in von willebrand factor

Human Gene Therapy

Volumn 11, Issue 7, 2000, Pages 983-993

  Hall, Frederick L ^a,b   Liu, Liqiong ^a,b   Zhu, Nian Ling ^b   Stapfer, Maria ^b   Anderson, W French ^a,c   Beart, Robert W ^b   Gordon, Erlinda M ^a,c  

^a Gene Therapy Laboratories   (United States)

^b Department of Colorectal Surgery ^*  (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR; VON WILLEBRAND FACTOR;

ARTHRITIS; ARTICLE; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; INFLAMMATORY DISEASE; ISCHEMIA; LIVER METASTASIS; METASTASIS; RETROVIRUS; WOUND HEALING;

AMINO ACID SEQUENCE; ANIMALS; CAROTID ARTERY INJURIES; CELL LINE; DRUG CARRIERS; EXTRACELLULAR MATRIX; GENE PRODUCTS, ENV; GENE THERAPY; GENETIC VECTORS; HUMANS; LEUKEMIA VIRUS, MURINE; LIVER NEOPLASMS; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; PANCREATIC NEOPLASMS; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; TRANSDUCTION, GENETIC; VON WILLEBRAND FACTOR;

ANIMALIA; MUS MUSCULUS; UNIDENTIFIED RETROVIRUS;

EID: 0034192369     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050015293     Document Type: Article

References (31)

1. Anderson, W.F. (1995). Gene therapy. Sci. Am. 273, 124-128.
2. Anderson, W.F. (1998). Human gene therapy. Nature (London) 392(Suppl.), 25-30.
3. Cosset, F.L., and Russell, S.J. (1996). Targeting retrovirus entry. Gene Ther. 3, 946-956.
4. Cosset, F.L., Morling, F.J., Takeuchi, U., Weiss, R.A., Collins, M.K., and Russell, S.J. (1995). Retroviral targeting by envelopes expressing an N-terminal binding domain. J. Virol. 69, 6314-6322.
5. Ginsburg, D., Konkle, B.A., Gill, J.C., Montgomery, R.R., Bockendstedt, P.L., Johnson, T.A., and Yang, A.Y. (1989). Molecular basis of human von Willebrand disease: Analysis of platelet von Willebrand mRNA. Proc. Natl. Acad. Sci. U.S.A. 86, 3723-3727.
6. Gordon, E.M., and Anderson, W.F. (1994). Gene therapy using retroviral vectors. Curr. Opin. Biotech. 5, 611-616.
7. Hall, F.L., Gordon, E.M., Wu, L., Zhu, N.L., Skotzko, M.J., Starnes, V.A., and Anderson, W.F. (1997). Targeting retroviral vectors to vascular lesions by genetic engineering of the MoMuLV gp70 envelope protein. Hum. Gene Ther. 8, 2183-2192.
8. Hunter, E., and Swanstrom, R. (1992). Retrovirus envelope glycoproteins. Curr. Top. Microbiol. Immunol. 157, 187-253.
9. Kasahara, N., Dozy, A.M., and Kan, Y.W. (1994). Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 266, 1373-1376.
10. Montgomery, R.R., Gill, J.C., and Scott, J.P. (1998). Hemophilia and von Willebrand disease. In Nathan and Oski's Hematology of Infancy and Childhood, 5th Ed., Vol II. D.G. Nathan and S.H. Orkin, eds. (W.B. Saunders, Philadelphia, PA) pp. 1631-1675.
11. Moritz, T., Dutt, P., Xiao, X., Carstanjen, D., Vik, T., Hanenberg, H., and Williams, D.A. (1996). Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: Evidence of direct viral binding to chymotryptic carboxy-terminal fragments. Blood 88, 855-862.
12. Peng, K.W., Morling, F.J., Cosset, F.L., Murphy, G., and Russell, S.J. (1997). A gene delivery system activatable by disease-associated matrix metalloproteinases. Hum. Gene Ther. 8, 729-738.
13. Pensiero, M.N., Wysocki, C.A., Nader, K., and Kikuchi, G.E. (1996). Development of amphotropic retrovirus vectors resistant to inactivation by human serum. Hum. Gene Ther. 8, 1095-1101.
14. Ruggeri, Z.M., and Zimmerman, T.S. (1987). von Williebrand factor and von Willebrand disease. Blood 70, 895-904.
15. Russell, S.J. (1993). Retroviral vectors displaying functional antibody fragments. Nucleic Acids Res. 21, 1081-1085.
16. Salmons, B., and Gunzburg, W. (1993). Targeting of retroviral vectors for gene therapy. Hum. Gene Ther. 4, 129-141.
17. Skotzko, M.J., Wu, L.T., Anderson, W.F., Gordon, E.M., and Hall, F.L. (1995). Retroviral vector-mediated gene transfer of antisense cyclin G1 (CYCGI) inhibits proliferation of human osteogenic sarcoma cells. Cancer Res. 55, 5493-5498.
18. Somia, N.V., Zoppe, M., and Verma, I.M. (1995). Generation of targeted retroviral vectors by using single-chain variable fragment: An approach to in vivo gene delivery. Proc. Natl. Acad. Sci. U.S.A. 92, 7570-7574.
19. Soneoka, Y., Cannon, P.M., Ramsdale, E.E., Griffiths, J.C., Gaetano, R., Kingsman, S.M., and Kingsman, A.J. (1995). A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23, 628-633.
20. Stromblad, S., and Cheresh, D.A. (1996). Cell adhesion and angiogenesis. Cell Biol. 64, 462-467.
21. Takaji, J., Fujisawa, T., Sekiya, F., and Saito, Y. (1991). Collagen-binding domain within bovine propolypeptide of von Willebrand factor. J. Biol. Chem. 266, 5575-5579.
22. Tuan, T.L., Cheung, L., Wu, L., Yee, A., Gabriel, S., Han, B., Morton, L., Nimni, M.E., and Hall, F.L. (1996). Engineering, expression and renaturation of targeted TGF-beta fusion proteins. Connective Tissue Res. 34, 1-9.
23. Valsesia-Wittman, S., Drynda, A., Deleage, G., Aumailley, M., Heard, J.M., Danos, O., Verdier, G., and Cosset, F.L. (1994). Modification in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors. J. Virol. 68, 4609-4619.
24. Verma, I., and Somia, N. (1997). Gene therapy: Promises, problems and prospects. Nature (London) 389, 239-242.
25. Weiss, R.A. (1993). Cellular receptors and viral glycoproteins involved in retrovirus entry. In The Retroviridae. J.A. Levy, ed. (Plenum Press, New York) pp. 1-108.
26. Weiss, R.A., and Tailor, C.S. (1995). Retrovirus receptors. Cell 82, 531-533.
27. White, J.M. (1992). Membrane fusion. Science 258, 917-924.
28. Wu, B.W., Cannon, P.M., Gordon, E.M., Hall, F.L., and Anderson, W.F. (1998). Characterization of the proline-rich region of murine leukemia virus envelope protein. J. Virol. 72, 5383-5391.
29. Yang, S., Delgado, R., King, S.R., Woffendin, C., Barker, C.S., Yang, Z.Y., Xu, L., Nolan, G.P., and Nabel, G.J. (1999). Generation of retroviral vector for clinical studies using transient transfection. Hum. Gene Ther. 10, 123-132.
30. Zhu, N.L., Wu, L., Liu, P.X., Gordon, E.M., Anderson, W.F., Starnes, V.A., and Hall, F.L. (1997). Down-regulation of cyclin G1 expression by retrovirus-mediated antisense gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation. Circulation 96, 628-635.
31. Zhu, N.L., Cannon, P.M., Chen, D., and Anderson, W.F. (1998). Mutational analysis of the fusion peptide of Moloney murine leukemia virus transmembrane protein p15E. J. Virol. 72, 1632-1639.